EUVIMEDEUVIMED entdecken
Crossref

Pioglitazone Improves Survival In Patients With Cancer: The Hypothesis

Banshi Saboo, Ivan Kruljac, Dario Rahelić

Endocrine Oncology and Metabolism · 2015

DOI: 10.21040/eom/000004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Oncology and Metabolism, 2015. Verfasst von Banshi Saboo und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Saboo, B., Kruljac, I., & Rahelić, D. (2015). Pioglitazone Improves Survival In Patients With Cancer: The Hypothesis. Endocrine Oncology and Metabolism. https://doi.org/10.21040/eom/000004

Vancouver

Saboo B, Kruljac I, Rahelić D. Pioglitazone Improves Survival In Patients With Cancer: The Hypothesis. Endocrine Oncology and Metabolism. 2015. doi:10.21040/eom/000004

BibTeX
@article{Saboo2015,
  author = {Saboo, Banshi and Kruljac, Ivan and Rahelić, Dario},
  title = {Pioglitazone Improves Survival In Patients With Cancer: The Hypothesis},
  journal = {Endocrine Oncology and Metabolism},
  year = {2015},
  doi = {10.21040/eom/000004}
}
Kostenlos starten →